Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed)

The National Institutes of Health, within the U.S. Department of Health and Human Services, is forecasting a limited competition funding opportunity titled Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed). This program is administered by the National Institute of General Medical Sciences and is designed to support advanced, established synchrotron-based technologies that serve the biomedical research community. These facilities provide critical infrastructure, including high-performance X-ray beamlines, technical expertise, and user training necessary for structural biology research. The primary purpose of this program is to sustain and enhance mature synchrotron resources that enable researchers to generate high-resolution structural data for biological macromolecules. These resources are essential for advancing fundamental biomedical discoveries, including understanding disease mechanisms and supporting drug development. The funding is intended to maintain state-of-the-art instrumentation, ensure accessibility for a broad user base, and provide expert guidance to researchers utilizing these facilities. Funding under this opportunity is provided through a P30 center grant mechanism and does not allow clinical trials. While specific funding amounts, award ceilings, and floors are not provided in the forecast, the program is expected to support national-scale infrastructure projects rather than individual research studies. There is no cost sharing or matching requirement specified, indicating that applicants are not required to contribute additional funds to receive support. Eligibility for this opportunity is broad across organizational types, including institutions of higher education, nonprofit organizations, government entities, and certain private sector organizations. However, a critical eligibility restriction applies: applicants must currently operate synchrotron resources that are actively supported by NIGMS funding. Additionally, resources whose funding has lapsed for more than 36 months prior to the application due date are not eligible, reinforcing the program’s focus on sustaining ongoing, mature infrastructure. The application process will follow NIH standard submission and peer-review procedures. This includes submission through established federal grant systems, compliance with NIH formatting and documentation requirements, and evaluation through a competitive peer review process. Only meritorious applications demonstrating strong scientific value, operational excellence, and broad community impact will be considered for funding. The opportunity is currently in forecast status, with an estimated posting date of August 13, 2026, and an application due date of October 13, 2026. Awards are expected to be issued by July 1, 2027, with project start dates aligned to that timeline. Interested applicants are encouraged to monitor updates and prepare in advance for submission. For additional information or inquiries, applicants may contact the program via the provided NIH email address.